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Schizophrenia is associated with an increase in cortical
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MicroRNA expression profiling and quantitative reverse transcription-PCR analysis of the
superior temporal gyrus and the dorsolateral prefrontal cortex revealed a significant
schizophrenia-associated increase in global microRNA expression. This change was
associated with an elevation of primary microRNA processing and corresponded with an
increase in the microprocessor component DGCR8. The biological implications for this
extensive increase in gene silencing are profound, and were exemplified by members of the
miR-15 family and other related microRNA, which were significantly upregulated in both brain
regions. This functionally convergent influence is overrepresented in pathways involved in
synaptic plasticity and includes many genes and pathways associated with schizophrenia,
some of which were substantiated in vitro by reporter gene assay. Given the magnitude of
microRNA changes and their wide sphere of influence, this phenomenon could represent an
important dimension in the pathogenesis of schizophrenia.
Molecular Psychiatry (2010) 15, 1176–1189; doi:10.1038/mp.2009.84; published online 1 September 2009
Keywords: schizophrenia; microRNA; miRNA; DGCR8; dicer
Introduction
Schizophrenia is a debilitating neuropsychiatric dis-
order characterized by a diverse range of symptoms
and neurocognitive impairments. Although its exact
pathogenesis remains obscure, there is a broad
consensus that schizophrenia is of neurodevelop-
mental origin, arising through the complex interplay
of numerous genetic and environmental factors.
1
Some insight into the molecular interactions within
this matrix has been provided by high-throughput
gene expression analyses of post-mortem brain tis-
sues.
2–6 These investigations have consistently shown
that numerous genes are affected in schizophrenia.
Although some of these changes reflect alterations in
known candidate genes and their downstream influ-
ences, most are inexplicable and their origins may lie
well beyond the reach of these well-known mechan-
isms. Despite the perplexing array of findings, there
are patterns in schizophrenia-associated gene expres-
sion that are indicative of systematic regulatory
dysfunction. In contexts where these coincide with
functional pathways, for example, in neurotransmit-
ter systems and neural development, they support
plausible hypotheses that correspond with our
limited understanding of schizophrenia pathophy-
siology. Efforts to understand the underlying mechan-
isms driving these changes in gene expression have
focused predominantly on genetic and epigenetic
influences on transcription, mediated by alterations
in signal-transduction pathways, their transcription
factors, or gene promoter elements and associated
chromatin structure. However, some recent studies
have emerged showing that post-transcriptional in-
fluences on gene expression mediated by changes in
non-coding microRNA (miRNA) expression are also
associated with schizophrenia.
7 We identified an
increase in miR-181b expression in the superior
temporal gyrus in schizophrenia and analyzed its
activity with respect to candidate genes suppressed in
the same tissue.
8 We now present evidence suggesting
that this represented a mere fraction of the overall
scale of schizophrenia-associated alteration in miR-
NA expression. This striking deviation in global
miRNA expression was observed in post-mortem
tissue from both the superior temporal gyrus (STG)
and the dorsolateral prefrontal cortex (DLPFC) and
seemed to involve an increase in miRNA biogenesis.
Materials and methods
Tissue collection and dissection
Fresh frozen post-mortem STG gray matter tissue from
21 subjects with schizophrenia and 21 non-psychia-
tric controls and DLPFC gray matter from 15 subjects
with schizophrenia and non-psychiatric controls was
obtained through the NSW Tissue Resource Centre,
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tissue was taken from the outer edge of blocks of STG
tissue that was obtained from the most caudal coronal
brain slice containing the STG (Brodmann’s Area 22)
or DLPFC (Brodmann’s Area 9). Dissections were
performed blind on coded tissue blocks such that
disease status was not identifiable during this
procedure. In all cases, a diagnosis of schizophrenia
in accordance with DSM-IV criteria was confirmed by
medical file review using the Item Group Checklist of
the Schedules for Clinical Assessment in Neuropsy-
chiatry and the Diagnostic Instrument for Brain
Studies. Consent was obtained from the next of kin,
and subjects with a significant history of drug or
alcohol abuse, or other condition or gross neuro-
pathology that might have influenced the agonal state
were excluded. In addition, control subjects were
excluded if there was a history of alcoholism or
suicide. All subjects were of Caucasian descent.
Subjects with schizophrenia were matched for gen-
der, age, brain hemisphere, postmortem interval (PMI)
and pH (Supplementary Table 1). The tissue was
dissected and RNA extracted as described earlier.
8
MicroRNA expression profiling
The microarray procedure was carried out as de-
scribed earlier,
9 with some alterations.
8 miRNAs were
labeled directly by a ligation approach using 3mg total
RNA. A synthetic reference library consisting of
oligonucleotides (representing the entirety of miR-
Base version 7.1) was labeled with Ulysis platinum-
conjugated AlexaFluor 647 (equivalent to Cy5) for
detection in the control channel, according to the
manufacturer’s instructions (Invitrogen, Carlsbad,
CA). The unconjugated label was then removed by
gel filtration through a Sephadex G-25 spin column
(GE Healthcare, Piscataway, NJ). The labeled refer-
ence library was used at 1/700 dilution, alongside the
Cy3-labeled miRNAs in each array hybridization.
Microarrays were prepared using anti-sense Locked
Nucleic Acid (LNA) oligonucleotides (Exiqon,
Vedbaek, Denmark) corresponding to the miRBase
Version 7.1, containing 322 human miRNA sequences.
The oligonucleotide probes were printed in quad-
ruplicate onto GAPS-2 glass slides (Corning, Lowell,
MA) by the Australian Genome Research Facility.
Feature deposition consistency was analyzed before
hybridization by examining spot autofluorescence
and after hybridization by comparing the reference
intensity (AlexaFluor 647) from probe replicates.
Single- and double-mismatch probes for a number of
miRNAs were also printed in quadruplicate to assess
the hybridization specificity. The slides were pre-
pared as described earlier
8 and hybridized for 2h at
551C in a rotary hybridization oven. Arrays were then
scanned and raw image extracted with a Genepix
4000B Scanner and Genepix Pro 3.0 software (Axon
Instruments, Sunnyvale, CA). Features with a median
Cy3 pixel intensity value more than 200% back-
ground had the background subtracted and were
normalized with respect to U6 small nuclear RNA
(snRNA) expression. Differential miRNA expression was
analyzed using Significance Analysis of Microarrays
(SAM) version 2.23 (Stanford University)
10 (available
from http://www-stat.stanford.edu/~tibs/SAM/). SAM
uses permutations of the data to determine whether
multiple differences are significantly related to
the disorder. The threshold for significance was
determined with respect to the false-discovery
rate. Any miRNA showing a false-discovery rate
<5% was considered as significantly altered. The
SAM analysis parameters were: two-class unpaired
analysis, t-test statistic and 5000 permutations of
the data.
Total RNA analysis
Total RNA from the STG was quantified using a RNA
Quant-it assay according to the manufacturer’s
instructions (Invitrogen). Individual and pooled
RNA samples (schizophrenia and control groups)
(100ngml
 1) were dephosphorylated in 1 SAP buffer
and 1 unit of shrimp alkaline phosphatase (Fermen-
tas, Vilnius, Lithuania) at 371C for 30min. After heat
inactivation, the dephosphorylated RNA was then
rephosphorylated in the presence of [
32P-g] adenosine
triphosphate in 1  polynucleotide kinase forward
reaction buffer and 1 unit of polynucleotide kinase
(Fermentas). Labeled RNA was then combined with
an equal volume of formamide/bromophenol blue/
25mM EDTA loading dye and denatured at 951C
before electrophoresis on a 16% denaturing (TBE/
Urea) sequencing gel. Images were generated and
analyzed from the radiolabeled gel using a Typhoon
phosphorimager and ImageQuant software (GE
Bioscience, Piscataway, NJ).
Quantitative reverse transcription-PCR (Q-PCR)
Reverse transcription and Q-PCR was conducted as
described earlier
8 with some adaption. Reactions
were carried out in a final volume of 12.5ml using a
7500 Real Time PCR system (Applied Biosystems,
Foster City, CA). For miRNA expression, the delta Ct
was calculated by subtracting the Ct of the endogen-
ous controls (geometric mean of U6 snRNA, U44
small nucleolar RNA (snoRNA) and U49 snoRNA)
from the Ct of the miRNA. For mRNA expression, the
delta Ct was calculated by subtracting the Ct of the
endogenous controls (geometric mean of b-glucuroni-
dase and hydroxymethylbilane synthase) from the Ct
of the mRNA. Primary miRNA (pri-miRNA) tran-
scripts and processed precursor miRNA (pre-miRNA)
hairpins were reverse transcribed using random
primers as described for mRNA.
8 Primers specific
for the pri-miRNAs were designed to amplify a
segment of the primary transcript upstream of the
precursor sequence. The pre-miRNA primers were
designed to hybridize to partially single-stranded
segments within the precursor hairpin in both the
precursor miRNA and the primary miRNA transcript.
A dissociation curve analysis was performed for every
Q-PCR reaction. A single peak was observed for all
reactions to confirm the specificity of the reaction.
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gel electrophoresis, in which products of the correct
size were observed on the gel.
Statistical analyses
The demographic characteristics for each cohort were
compared using Student’s t-tests to verify matching
for age, PMI and tissue pH. PMI was higher in the
DLPFC schizophrenia group (29.9±11.0h) when
compared with the control group (21.9±9.9h;
P=0.045). The Kolmogorov–Smirnov test for normal-
ity was used to determine whether each data set was
normally distributed to satisfy the conditions for
parametric statistics (Prism 4.00, GraphPad Software,
Inc., La Jolla, CA). To determine the significance of
differential miRNA expression between the two
cohorts, an un-paired one-tailed t-test was applied.
Differential gene expression (mRNA) was determined
by un-paired two-tailed Student’s t-tests, in which
significance was considered as P<0.05. In addition,
Pearson’s product moment correlations were per-
formed for miRNA/mRNA expression levels and the
demographic variables (age, PMI and pH) using
control data. Where expression showed correlation,
the significance was further tested for analysis of
covariance (ANCOVA) using the demographic vari-
able as a covariate (SPSS Statistics 17.0, SPSS Inc.,
Chicago, IL).
Target gene and pathway analyses
Putative target genes were identified using the
publically available database, TargetCombo (which
combines information gathered from multiple data-
bases such as Diana-microT, PicTar, TargetScanS
and miRanda; available at http://www.diana.pcbi.
upenn.edu/cgi-bin/TargetCombo.cgi). Pathway ana-
lyses of the target gene lists were carried out using
the Database for Annotation, Visualization, and
Integrated Discovery bioinformatics resource (avail-
able at http://david.abcc.ncifcrf.gov/).
Cell culture, transfection and target gene reporter assay
Human embryonic kidney cells (HEK)-293 cell cul-
tures were maintained as confluent monolayers at
371C with 5% CO2 and 90% humidity in Dulbecco’s
modified Eagles’s medium (DMEM) with 10%
(volvol
 1) fetal calf serum, 20mM HEPES (4-(2-
hydroxyethyl)-1piperazineethanesulfonic acid), 0.15%
(wtvol
 1) sodium bicarbonate and 2mML -glutamine.
Cells were seeded into 24-well plates and transfected
24h later using Lipofectamine 2000 (Invitrogen). In
each case transfections were performed according to
the manufacturer’s instructions, with 100nM syn-
thetic miRNA or anti-miR oligonucleotide (Table 1).
Validation of predicted target genes was accom-
plished by co-transfecting HEK293 cells with syn-
thetic miRNA or an LNA-modified antisense inhibitor
and recombinant firefly luciferase reporter gene
constructs containing 30-UTR sequences substituted
from the target gene. Oligonucleotides encoding target
gene miRNA recognition elements were annealed to
form SpeI and HindIII restricted overhangs of a
ligatable cassette compatible with SpeI and HindIII
digested pMIR-REPORT vector (Ambion, Austin, TX)
(Table 1). Reporter gene silencing in response to
miRNA co-transfection was monitored with respect to
a control plasmid expressing renilla luciferase using
the dual-luciferase reporter assay (Promega, Madison,
WI). To control for the nonspecific effects associated
with siRNA transfection, the controls were co-trans-
fected with mutant miRNAs or mutant anti-miRs. The
miR-15 family miRNAs (that share an identical seed
pairing region) were all controlled with a mutant form
of miR-16 containing a scrambled seed-pairing region.
Transfection of miR-107 was controlled by a mutant
control version of miR-107 containing a scrambled
seed pairing sequence. Although these reporter gene
constructs, consisting of the miRNA recognition
elements (MREs) and a small amount of 30-UTR (Table
1), are useful for evaluating target–miRNA interac-
tions, the reporter genes’ mRNA secondary structure
will be different from that of the native transcript and
could positively or negatively influence the extent of
gene silencing observed.
Results
Elevation of miRNA expression in the STG in
schizophrenia
Changes in miRNA expression have broad implica-
tions for disease, as each miRNA molecule is capable
of influencing the expression of hundreds of target
genes. The expression of miRNA has been shown to
be important during development, particularly in the
mammalian brain;
11 therefore, it is plausible that
these molecules have great significance in neurode-
velopmental disorders such as schizophrenia. In this
study, we analyzed miRNA expression in the STG
(Brodmann’s Area 22, 17 matched pairs of schizo-
phrenia and non-psychiatric controls) and the DLPFC
(Brodmann’s Area 9, 15 matched pairs), using a
microarray printed with LNA-modified capture
probes corresponding to miRBase version 7.1 (Ex-
iqon).
9 In contrast to our earlier study, which
identified two differentially expressed miRNAs in a
relatively small cohort of STG tissue normalized by
global miRNA expression,
8 these arrays were also
furnished with two probes specific for different sites
in the U6 snRNA that enabled external or miRNA-
independent normalization of miRNA expression
between samples. In this new analysis, miR-181b
(earlier found to be upregulated in the STG) repre-
sented only one of many significantly elevated
miRNAs in the schizophrenia group. This observa-
tion, apparent in scatter plots of the average expres-
sion between schizophrenia and controls for each
miRNA (Figure 1a), implied there was a schizophre-
nia-associated global elevation of miRNA expression
in the STG. The significance of these changes was
supported by SAM analysis, which reported that 59
miRNAs (or 21% of the miRNAs expressed in the
STG) were upregulated (Supplementary Table 2).
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Type Name Sequence Target
Primers
a U6-probe 50-GCCATGCTAATCTTCTCTGTATC-30 U6 snRNA
U6-F339 50-CGGCAGCACATATACTAAAATTGG-30 U6 snRNA
U49-F 50-ATCACTAATAGGAAGTGCCGTC-30 U49 snoRNA
U49-R 50-ACAGGAGTAGTCTTCGTCAGT-30 U49 snoRNA
U44-F 50-TGATAGCAAATGCTGACTGA-30 U44 snoRNA
U44-R 50-CAGTTAGAGCTAATTAAGACC-30T U44 snoRNA
107-F 50-AGCAGCATTGTACAG-30 miR-107
107-R 50-GTAAAACGACGGCCAGTTGATAGCC-30 miR-107
15a-F
b 50-TþAGþCAGCACATAA-30 miR-15a
15a-R 50-GTAAAACGACGGCCAGTCACAAACCA-30 miR-15a
15b-F 50-TAGCAGCACATCAT-30 miR-15b
15b-R 50-GTAAAACGACGGCCAGTTGTAAACC-30 miR-15b
16-F 50-TAGCAGCACATCAT-30 miR-16
16-R 50-GTAAAACGACGGCCAGTTGTAAACC-30 miR-16
128a-F 50-TCACAGTGAACCG-30 miR-128a
128a-R 50-GTAAAACGACGGCCAGTAAAAGAGAC-30 miR-128a
181a-F 50-AACATTCAACGCTG-30 miR-181a
181a-R 50-GTAAAACGACGGCCAGTACTCACCGA-30 miR-181a
181b-F 50-TTTCTAACATTCATTGCT-30 miR-181b
181b-R 50-CAACCTTCTCCCACCGAC-30 miR-181b
195-F 50-TþAGCAGCACAGA-30 miR-195
195-R 50-GTAAAACGACGGCCAGTGCCAATATT-30 miR-195
19a-F 50-TGTGCAAATCTATGC-30 miR-19a
19a-R 50-GTAAAACGACGGCCAGTTCAGTTTT-30 miR-19a
20a-F 50-TþAAþAGTGCTTATAGTG-30 miR-20a
20a-R 50-GTAAAACGACGGCCAGTCTACCTG-30 miR-20a
219-F 50-TþGATþTGTCCAAAC-30 miR-219
219-R 50-GTAAAACGACGGCCAGTAGAATTGC-30 miR-219
26b-F 50-TTþCAþAGTAATTCAGG-30 miR-26b
26b-R 50-GTAAAACGACGGCCAGTAACCTAT-30 miR-26b
27a-F 50-TTþCACAGTGGCTA-30 miR-27a
27a-R 50-GTAAAACGACGGCCAGTGCGGAACT-30 miR-27a
29b-F 50-TþAGþCACCATTTGAA-30 miR-29c
29c-R 50-GTAAAACGACGGCCAGTTAACCGAT-30 miR-29c
338-F 50-AAþCAATATCCTGGT-30 miR-338
338-R 50-GTAAAACGACGGCCAGTCACTCAGC-30 miR-338
7-F 50-TþGGAAGACTAGTGA-30 miR-7
7-R 50-GTAAAACGACGGCCAGTACAACAAAA-30 miR-7
let-7d-F 50-AGAþGGTAGTAGGTT-30 let-7d
let-7d-R 50-GTAAAACGACGGCCAGTAACTATGC-30 let-7d
let-7e-F 50-TGþAGGTAGGAGGT-30 let-7e
let-7e-R 50-GTAAAACGACGGCCAGTACTATACA-30 let-7e
M13-F 50-GTAAAACGACGGCCAGT-30 Rev primer for
miRNA Q-PCR
GUSB-F 50-GCCAATGAAACCAGGTATCCC-30 GUSB
GUSB-R 50-GCTCAAGTAAACAGGCTGTTTTCC-30 GUSB
HMBS-F 50-GAGAGTGATTCGCGTGGGTA-30 HMBS
HMBS-R 50-CAGGGTACGAGGCTTTCAAT-30 HMBS
FXR2-F 50-ACCGCCAGCCAGTGACTGTG-30 FXR2
FXR2-R 50-AGTCACCCTTCTGTCCTGAAA-30 FXR2
DICER1-F 50-CACATCAATAGATACTGTGCT-30 DICER
DICER-R 50-TTGGTGGACCAACAATGGAGG-30 DICER
DGCR8-F 50-GCTGAGGAAAGGGAGGAG-30 DGCR8
DGCR8-R 50-ACGTCCACGGTGCACAG-30 DGCR8
DROSHA-F 50-AAGCGTTAATAGGAGCTGTTTACT-30 DROSHA
DROSHA-R 50-CGTCCAAATAACTGCTTGGCT-30 DROSHA
XPO5-F 50-ATATATGAGGCACTGCGCC-30 EXP-5
XPO5-R 50-AAACTGGTCCAGTGAGTCCTT-30 EXP-5
DDX26-F2 50-AGATCCGAAAGCCAGGAAGAAAA-30 DDX26
DDX26-R2 50-TTTGTAAACTGCCTTGCACATGC-30 DDX26
DDX5-F 50-AAGGATGAAAAACTTATTCGT-30 DDX5
DDX5-R 50-TTTTCCATGTTTGAATTCATT-30 DDX5
DDX17-F 50-GTGAAAAAGACCACAAGTTGA-30 DDX17
DDX17-R 50-TACACATAGCTGGCCAACCAT-30 DDX17
FXR2-F 50-ACCGCCAGCCAGTGACTGTG-30 FXR2
FXR2-R 50-AGTCACCCTTCTGTCCTGAAA-30 FXR2
pri-181b-2-F1 50-AAGAAGAGCCAGGAGTCAGC-30 pri-181b-2
pri-181b-2-R1 50-TCAGTTGGTGGGGTTGCCTT-30 pri-181b-2
pre-181b-2-F 50-CTGATGGCTGCACTCAACAT-30 pre-181b
Schizophrenia and cortical microRNA biogenesis
NJ Beveridge et al
1179
Molecular PsychiatryWith the apparent scope of this alteration in small
RNA expression, we considered that it might be
possible to directly visualize this in the small RNA
fraction of
32P-labeled total RNA separated on a
sequencing gel. On pooled samples this experiment
revealed that the B22-nt band (corresponding to the
miRNAs) was 1.5 times more intense for the schizo-
phrenia sample than that of the controls (normalized
to the B75-nt tRNA band) (Figure 1b). In individual
samples, the schizophrenia-associated increase in the
Table 1 Continued
Type Name Sequence Target
pre-181b-2-R 50-TGATCAGTGAGTTGATTCAGACT-30 pre-181b
pri-26b-F 50-CCGTGCTGTGCTCCCT-30 pri-26b
pri-26b-R 50-CGAGCCAAGTAATGGAGAACAG-30 pri-26b
pre-26b-F 50-GACCCAGTTCAAGTAATTCAGGA-30 pre-26b
pre-26b-R 50-CGAGCCAAGTAATGGAGAACAG-30 pre-26b
Cassettes
c VSNL1-107-T 50-CTAGTTCCTCCAAAGCCTGGGCAGAAATGTGCTGCAAA-30 VSNL1
VSNL1-107-B 50-AGCTTTTGCAGCACATTTCTGCCCAGGCTTTGGAGGAA-30 VSNL1
RELN-107-T 50-CTAGTTTACTTGTTATGTTGTAATATTTTGCTGCTGAATTT-30 RELN
RELN-107-B 50-AGCTAAATTCAGCAGCAAAATATTACAACATAACAAGTAAA-30 RELN
HTR2A-107-T 50-CTAGCTATTTTCAAGTGGAAACCTTGCTGCTATGCTGTTCA-30 HTR2A
HTR2A-107-B 50-AGCTTGAACAGCATAGCAGCAAGGTTTCCACTTGAAAATAG-30 HTR2A
GRIN3A-107-T 50-CTAGGCACAAACCCTATCAAGAGCTGCTGCTTCCCT-30 GRIN3A
GRIN3A-107-B 50-AGCTAGGGAAGCAGCAGCTCTTGATAGGGTTTGTGC-30 GRIN3A
PLEXNA2-107-T 50-CTAGGACAGTTCTGCCTCTGTGACTGCTGCTTTGCATG-30 PLEXNA2
PLEXNA2-107-B 50-AGCTCATGCAAAGCAGCAGTCACAGAGGCAGAACTGTC-30 PLEXNA2
DLG4-107-T 50-CTAGGTCCGGGAGCCAGGGAAGACTGGAAATGCTGCCG-30 DLG4
DLG4-107-B 50-AGCTCGGCAGCATTTCCAGTCTTCCCTGGCTCCCGGAC-30 DLG4
DRD1-107-T 50-CTAGAATTTACGATCTTAGGTGGTAATGAAAAGTATATGCTGCTTTG-30 DRD1
DRD1-107-B 50-AGCTCAAAGCAGCATATACTTTTCATTACCACCTAAGATCGTAAATT-30 DRD1
GRM7-107-T 50-CTAGGTTTGTAATAAGTACTTTCGTTAATCTTGCTGCTTATGTG-30 GRM7
GRM7-107-B 50-AGCTCACATAAGCAGCAAGATTAACGAAAGTACTTATTACAAAC-30 GRM7
RGS4-107-T 50-AATGCACTAGTCCACATTGTAGCCTAATATTCATGCTGCCTGCCA
TGAAGCTTAATGC-30
RGS4
RGS4-107-B 50GCATTAAGCTTCATGGCAGGCAGCATGAATATTAGGCTACAATGTGGA
CTAGTGCATT-30
RGS4
miRNA
d miR-107þ 50-AGCAGCAUUGUACAGGGCUAUCA-30 miR-107
miR-107  50-AUAGCCCUGUACAAUGCUGUAUU-30 miR-107
miR-15aþ 50-UAGCAGCACAUAAUGGUUUGUG-30 miR-15a
miR-15a  50-CAAACCAUUAUGUGCUGUUAUU-30 miR-15a
miR-15bþ 50-UAGCAGCACAUCAUGGUUUACA-30 miR-15b
miR-15b  50-UAAACCAUGAUGUGCUGUUAUU-30 miR-15b
miR-16þ 50-UAGCAGCACGUAAAUAUUGGCG-30 miR-16
miR-16  50-CCAAUAUUUACGUGCUGUUAUU-30 miR-16
miR-195þ 50-UAGCAGCACAGAAAUAUUGGC-30 miR-195
miR-195  50-CAAUAUUUCUGUGCUGUUAUU-30 miR-195
control-miRNA-1þ 50-AUCCACCACGUAAAUAUUGGCG-30 miR-15 family
control-miRNA-1  50-CCAAUAUUUACGUGGUGGAUCG-30 miR-15 family
control-miRNA-2þ 50-UCCACCAAUGUACAGGGCUAUCA-30 miR-107
control-miRNA-2  50-AUAGCCCUGUACAUUGGUGAAUU-30 miR-107
Anti-miRs
e Anti-miR-107 50-TþGATþAGCþCCTþGTAþCAAþTGCþTG-30 miR-107
Anti-miR-15a 50-CþACAþAACþCATþTAT þGTGþCTGþCTA-30 miR-15a
Anti-miR-15b 50-TþGTAþAACþCATþGATþGTGþCTGþCTA-30 miR-15b
Anti-miR-16 50-CþGCCþAATþATT þTAC þGTGþCTGþCTA-30 miR-16
Anti-miR-195 50-GþCCAþATA þTTTþCTGþTGCþTGCþTA-30 miR-195
Control anti-miR-1 50-CþGCCþAATþATT þTAC þGTGþGTGþGAT-30 miR-15 family
Control anti-miR-2 50-TþGATþAGCþCCTþGTAþCATþTGGþTG-30 miR-107
aThe direction of primers with respect to the target sequence was denoted as either F or R for forward and reverse,
respectively. The underlined sequence is not gene specific and was used to provide a primer recognition sequence. For
miRNA Q-PCR, the Rev primer is used for reverse transcription, and the For primer is used in the Q-PCR with M13-F as the
reverse primer.
bThe positions of LNA-modified bases are preceded by a ‘þ’ symbol.
cSpeI/HindIII cassettes containing putative target recognition elements were used to generate recombinant luciferase reporter
gene constructs. ‘T’ indicates top strand and ‘B’ indicates bottom strand.
dSynthetic miRNAs are used to over-express microRNA. ‘þ’ indicates top strand and ‘–‘ indicates bottom strand.
eAnti-miRs are used to suppress endogenous microRNA.
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a general increase in small RNA expression in
schizophrenia (Supplementary Table 3).
For more specific evidence of this phenomenon,
Q-PCR assays for 10 miRNAs shown to be among the
most significantly upregulated by microarray analysis
were established. The relative expression values for
each miRNA across an extended cohort, consisting of
21 schizophrenia samples and 21 matched controls of
post-mortem cortical gray matter from the STG, were
normalized with respect to the geometric mean of
three constitutively expressed small RNAs (including
U6 snRNA, U44 and U49 snoRNA) (Figure 1c). In
each case the level of concordance with the micro-
array and Q-PCR was very high, and in many cases
the average schizophrenia-associated increase was
even greater by Q-PCR than that observed by micro-
array. This trend was also highly visible in individual
samples clustered by expression and visualized by
heat map (Figure 1d). Unsupervised clustering of
these differentially expressed miRNAs was character-
ized by a high degree of segregation between the
schizophrenia and control groups. Prominent among
this group of miRNAs associated with schizophrenia
was the apparent upregulation of the miR-15 family
miRNAs such as miR-15a, miR-15b and miR-195, all of
which share the same functionally important seed-
pairing region and consequently a large proportion of
target genes. In addition, miR-107 was among the most
significantly upregulated miRNA in the STG and also
shared a high degree of seed region homology with the
miR-15 family (Figure 1c). Collectively they are
predicted to target a wide array of target genes, with
many of them implicated in schizophrenia, such as
brain BDNF, NRG1, RELN, DRD1, HTR4, GABR1,
GRIN1, GRM7, CHRM1 and ATXN2.
Elevation of miRNA expression in the DLPFC in
schizophrenia
In view of the possibility that these changes in
miRNA expression were merely STG-related phenom-
ena, we initiated a similar investigation of the DLPFC
(BA9), a region most frequently identified in the
neuropathology of schizophrenia. Total RNA from
post-mortem gray matter from a cohort of 15 cases
with a history of schizophrenia and 15 matched
controls with no record of psychiatric illness was
extracted and subjected to microarray analysis as
described for the STG. The miRNA expression profile
in this tissue was similar to that in the STG, with 274
expressed miRNAs (compared with 280 in the STG).
Importantly, the DLPFC showed a schizophrenia-
associated global increase in miRNA expression that
was broadly consistent with the observations in the
STG (Figure 2a). According to SAM analysis, 26
(9.5%) of the miRNAs expressed in the DLPFC were
significantly upregulated, such as miR-181b, miR-16
and miR-20a, which were also increased in the STG.
Again, to validate the microarray results, Q-PCR
assays were performed on a subset of 10 differentially
expressed miRNAs as described for the STG, using
the expression of three constitutively expressed small
RNAs as a reference. This analysis supported the
array findings and in some cases exceeded the
expectation by showing an even stronger schizophre-
nia-associated upregulation in miRNAs (Figure 2b).
To determine whether the differentially expressed
miRNAs in common extended beyond the scope
identified by SAM analysis of the DLPFC microarray
experiment, the DLPFC samples were also examined
for the remaining schizophrenia-associated miRNAs
validated for the STG cohort. These miRNAs, includ-
ing let-7e, miR-19a, miR-26b, miR-107 and the
remaining members of the miR-15 family, were all
found to be significantly upregulated in the DLPFC by
Q-PCR (Figure 2c). In a manner similar to the STG
cohort, unsupervised hierarchical clustering of miR-
NA expression in individual DLPFC samples also
produced very good segregation between the schizo-
phrenia and control groups (Figure 2d).
Altered miRNA biogenesis in the STG and DLPFC
The scope and consistency of the schizophrenia-
associated increase in miRNA expression led us to
consider both miRNA processing and the activity of
genes in the miRNA biogenesis pathway in this
context. For this purpose, we analyzed the relative
expression of pri-miRNA and pre-miRNA in addition
to the mature miRNA transcripts for miR-181b and
miR-26b. Interestingly, although there was a signifi-
cant increase in pre-miRNA species (consistent with
the mature miR-181b and miR-26b), there was no
difference in transcription of the pri-miRNA, or the
host gene mRNA (CDTSP1) for the intronic miR-26b
(Figure 3b). This supported the hypothesis that there
was a schizophrenia-associated increase in miRNA
biogenesis rather than any change at the level of
miRNA transcription. To further support this asser-
tion, we examined the expression of the micropro-
cessor constituents Drosha and DGCR8 involved in
primary miRNA processing.
12 The mRNA for both of
these microprocessor components was found to be
significantly upregulated in the DLPFC, and DGCR8
was also upregulated in the STG (Figure 3c).
Importantly, DGCR8 was shown to be upregulated in
13 of the 15 matched pairs of DLPFC tissue, and in 16
of the 21 matched pairs of STG when analyzed as
matched pairs rather than by their cohort-wide
average (Figure 3d). These microprocessor compo-
nents are thought to be rate limiting in the miRNA
biogenesis pathway,
13 and, as a consequence, their
elevation in schizophrenia represents a highly plau-
sible explanation for the corresponding increase in
both pre-miRNA and mature miRNA expression. The
expression of additional genes implicated in primary
miRNA processing, such as the deadbox helicases
DDX5 and DDX17, were also examined. Neither of
these genes, however, was significantly altered in
either part of the cerebral cortex. The difference in
magnitude observed in differential miRNA and pre-
miRNA expression (Figure 3b) was possibly due to
some dilution of the pre-miRNA by pri-miRNA
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to amplify both of these sequences. However, it is also
conceivable that other influences downstream of the
microprocessor could further elevate mature miRNA
expression and contribute to this difference. In this
regard, we examined the expression of Exportin-5,
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also significantly upregulated in schizophrenia in the
DLPFC (Figure 3c). Dicer remained significant after
ANCOVA using brain pH as a covariate, despite
showing some correlation with pH in the DLPFC
(r= 0.553; F=4.26; d.f.=1, 27; P=0.048).
Target genes and pathways associated with miR-107
and miR-15 family microRNAs
To gain some appreciation of the biological implica-
tions of changes in miRNA expression observed in
schizophrenia, we examined predicted miRNA
targets and their associated pathways to see whether
any patterns emerged. A conspicuous aspect of
miRNA expression analyses in the STG and DLPFC
was the prominence of all members of the miR-15
family and miR-107, all of which share a similar seed
region (Figure 4a). To ascertain an overall perspective
of this influence, a collection of predicted target genes
derived using a range of search algorithms (collated
on the TargetCombo web service http://www.
diana.pcbi.upenn.edu/cgi-bin/TargetCombo.cgi)
14 was
subjected to pathway analysis using the Database for
Annotation, Visualization, and Integrated Discovery
bioinformatics resource (http://david.abcc.ncifcrf.
gov/tools.jsp)
15 Predicted target genes common to
the miR-15 family and miR-107 were highly enriched
in pathways involved in neural connectivity
and synaptic plasticity, such as axon guidance, long-
term potentiation, Wingless/int (Wnt), epidermal
growth factor receptor family (ErbB) and Mitogen-
activated protein (MAP) kinase signaling (Supple-
mentary Table 4). These processes are repeatedly
implicated in the pathophysiology of schizophrenia
and a number of individual genes have been shown to
be associated with schizophrenia.
Target gene silencing in vitro
To substantiate a link between these schizophrenia-
associated target genes and altered expression in this
group of miRNAs, the respective MREs from nine
target genes, such as RGS4, GRM7, GRIN3A, HTR2A,
RELN, VSNL1, DLG4, DRD1 and PLXNA2, were
cloned into the 30-UTR region of a luciferase reporter
gene construct and co-transfected into a recipient cell
line with miRNA or anti-miRs (miRNA antagonists).
The extent of reporter gene activity and the influence
of miRNAs were then determined by measuring the
relative luciferase activity (Figure 4c).
16 Many of these
constructs behaved in accordance with the expecta-
tion and were significantly repressed in the presence
of synthetic miRNA, and significantly de-repressed
(increased luciferase) in the presence of the corre-
sponding anti-miR (Figure 4c, Supplementary
Table 5). The most consistently responsive targets
were derived from the 30-UTR of RGS4, GRM7,
GRIN3A and RELN, whereas the least responsive
was PLXNA2. With respect to the miRNA, miR-107
appeared to have the greatest overall effect, whereas
miR-195 had the least effect on these target gene
constructs. Collectively, these reporter assays showed
a potential relationship between genes reported to be
associated with schizophrenia and a large function-
ally related group of upregulated miRNAs.
Discussion
Analysis of the post-mortem brain tissue from two
regions of the cerebral cortex in schizophrenia
revealed a substantial alteration of the post-transcrip-
tional regulatory environment, characterized by a
global increase in miRNA expression. This change
could have profound implications for the develop-
ment and ongoing pathophysiology of the disorder, as
each miRNA has the capacity to regulate the expres-
sion of hundreds of target genes. Studies in model
systems have highlighted the significance of miRNA
expression in brain development and a host of more
specific neurobiological functions, such as regulation
of the left–right asymmetry, long-term potentiation
and establishment or maintenance of dendrites.
17–21
In this work, we focused on the implications of
miRNAs in the miR-15 family and closely
related miR-107 as these functionally convergent
miRNAs were consistently upregulated in both
regions of the cerebral cortex in schizophrenia, and
could collectively contribute a significant biological
influence.
The miR-15 family of miRNAs has already been
shown to have an important role in chronic lympho-
cytic leukemia, with a well-characterized association
between a reduction of miR-15a/miR-16 concentra-
tion and increased expression of the anti-apoptosis
gene BCL2.
22 The relationship between miR-15 family
Figure 1 Schizophrenia-associated miRNA expression in the superior temporal gyrus (STG). (a) Average fold change of
miRNA expression (schizophrenia to control) was plotted against log2-transformed fluorescence values (n=17 matched
pairs). A global increase in miRNA expression in the STG in schizophrenia is indicated by the majority of miRNA showing a
ratio >1.0. (b) Electrophoresis of dephosphorylated total RNA (pooled samples) labeled with polynucleotide kinase (PNK).
Whole lane densitometry of the phosphor image indicated an increase in small RNA in the schizophrenia cohort (pink trace)
compared with the controls (blue trace), particularly in the small RNA fraction (20–24nt) region corresponding to most
miRNAs (indicated by long arrow). Densitometry was normalized to the B75-nt band in each lane (indicated by short arrow).
(c) Increased miRNA expression in the STG was validated using quantitative real-time reverse transcription-PCR (Q-PCR)
(n=21 matched pairs). Level of expression for controls was set at 1. Bars are meanþs.e.m. *P<0.05; **P<0.01;
***P<0.001;þmiR-16 and miR-19a were significant by t-test but were found to correlate with pH (r= 0.459 and  0.443,
respectively) and fell short of significance by analysis of covariance. (d) Q-PCR expression data hierarchically clustered
(correlation uncentered, average linkage; Cluster 3.0). Blue indicates low expression and yellow indicates high expression
(Java Treeview; http://www.sourceforge.net/projects/jtreeview/files).
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implications in schizophrenia, which has been
associated with a downregulation of BCL2 expression.
Reduced BCL2 expression in schizophrenia, perhaps
in response to increased miR-15 family expression, is
thought to contribute to elevated cortical apoptosis,
cerebral atrophy and even a reduction in the risk of
some forms of cancer.
23–25
Pathway analysis of predicted target genes sug-
gested that there are probably many other ways of
influence of this group of miRNAs that are of
significance to schizophrenia, such as axon guidance,
long-term potentiation, WNT, ErbB and MAP kinase
signaling (Supplementary Table 4). Many of these
predicted target genes, such as RGS4, GRM7, GRIN3A,
HTR2A, RELN, VSNL1, DLG4, DRD1 and PLXNA2,
have been shown to be associated with schizophre-
nia.
26–33 In relation to the current study, RGS4 and
VSNL1 were reported to be downregulated in the
same STG tissue;
8,34 however, the expression of these
and other candidate genes has not been analyzed at
the protein level in these cohorts. To further examine
the potential for a functional relationship between
MREs in these candidate genes and the miR-15-
related miRNAs, we established luciferase reporter
constructs and measured the degree of silencing from
individual miRNA. Regulation of 30-UTR elements
from the metabotropic glutamate receptor GRM7 and
the N-methyl-D-aspartic acid (NMDA) receptor sub-
unit GRIN3A was particularly strong and, along with
DLG4 (PSD95; scaffold protein that supports these
and other receptors in the post-synaptic density),
provides a post-transcriptional mechanism that could
underlie the many accounts of schizophrenia-asso-
ciated glutamatergic hypofunction.
35 It may also
explain the apparent conflict between the schizo-
phrenia-associated reduction of region-specific pro-
tein expression in the absence of change or even
paradoxical increase in corresponding mRNA.
36 An-
other target gene element that showed a consistent
response to miR-107 and the miR-15 family miRNAs
was one derived from the Reelin (RELN)3 0-UTR.
RELN is a secreted glycoprotein involved in neuronal
migration and synaptogenesis during development. It
is also important for the establishment of long-term
memory in the adult brain because of its role in the
modulation of synaptic activity and dendritic spine
development.
37 RELN is a highly plausible candidate
gene and its expression has been shown to be altered
in schizophrenia.
30,38 Although this alteration has
been associated with epigenetic regulation though
promoter hypermethylation,
39,40 it is now conceivable
that post-transcriptional gene silencing is also con-
tributing to RELN dysregulation in schizophrenia.
Collectively, these experiments were broadly sup-
portive of a role for this group of miRNAs in the
regulation of schizophrenia-associated target genes;
however, the response was quite variable for the
individual miRNAs, with miR-107 showing the most
consistent activity, whereas miR-195 appeared to
have the least activity against the elements tested
Figure 2 Schizophrenia-associated miRNA expression in
the dorsolateral prefrontal cortex (DLPFC). (a) miRNA
expression in the DLPFC in schizophrenia was character-
ized by the global upregulation illustrated in this scatter
plot (see Figure 1a for description), with the majority of
individual miRNAs showing a ratio >1.0. (b) Increased
miRNA expression in the DLPFC was validated using
quantitative real-time reverse transcription-PCR (Q-PCR)
(n=15 matched pairs). Level of expression for controls was
set at 1. (c) Further Q-PCR expression analysis indicated
that 11 miRNAs with altered expression showed an
upregulation in both the superior temporal gyrus and
DLPFC. Bars indicate mean fold changeþs.e.m. *P<0.05;
**P<0.01; ***P<0.001. (d) Q-PCR expression data were
subjected to hierarchical clustering and heat map, shown as
described in Figure 1d.
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195 (among others) was capable of regulating BDNF
expression in vitro.
41 The temporal and spatial
expression pattern of this miR-15 family member in
the DLPFC was inversely correlated with BDNF and
may be important for the developmental regulation of
this schizophrenia candidate gene.
Experiments in animal systems may also provide
important insight into the behavioral consequences of
altered cortical miRNA expression. In a recent study,
mice treated with the NMDA receptor antagonist
MK801 and hypomorphic GRIN1 (NR1) mutants
showed a marked decrease in miR-219 expression.
42
CaMKIIg, a predicted target gene for this miRNA
involved in NMDA signaling, was shown to be
sensitive to miR-219 concentration in vitro. Moreover,
suppression of miR-219 expression via intraventricu-
lar delivery of the corresponding LNA-modified
anti-miR restored MK801 induced neurobehavioral
dysfunction back to levels approaching that of the
controls.
42 Interestingly, in our study miR-219 was
the most highly upregulated miRNA in the DLPFC
and, in addition to the miR-15 family-related miRNA,
could also be mediating a schizophrenia-associated
reduction in NMDA signaling. These observations
add support to the idea that these altered miRNAs
are influential in the regulation of schizophrenia-
associated genes and provide the basis of a model
for the influence of disease-related miRNAs on
genes involved in synaptic structure and function
(Figure 5).
Although the examples of gene–miRNA interac-
tions mentioned above and modeled in Figure 5
provide a conceptual framework for the mechanisms
that may take place in the context of cortical miRNA
dysregulation, they may only touch the surface of the
broader ramifications for gene regulation in this
altered environment. In this regard, it is worth noting
that gene expression profiles in the same STG cohort
(albeit smaller than the one examined in this study)
Figure 3 Alterations in miRNA processing in schizophre-
nia. (a) Simplified schematic of miRNA biogenesis showing
genes involved in key enzymatic steps. (b) Primary,
precursor and mature transcripts for miR-181b were
analyzed by Q-PCR in the superior temporal gyrus (STG).
The primary transcript was not altered in schizophrenia;
however, the precursor and mature transcripts were both
upregulated 1.4-fold (P=0.048) and 1.7-fold (P=0.039),
respectively. The host gene of miR-26b (CDTSP1) and
primary transcript were not altered. The precursor and
mature miR-26b transcript were both upregulated in
schizophrenia (1.5-fold (P=0.023) and 1.9-fold (P=0.001),
respectively). In the dorsolateral prefrontal cortex (DLPFC),
a similar trend followed. Host gene and primary transcripts
were not altered in schizophrenia. For miR-181b, the
precursor and mature were upregulated 1.5-fold (P=0.043)
and 1.4-fold (P=0.039), respectively. For miR-26b, the
precursor and mature were upregulated 1.6-fold (P=0.046)
and 2.2-fold (P=0.001), respectively. (c) Expression of
miRNA biogenesis genes was analyzed in the STG (n=21
matched pairs) and the DLPFC (n=15 matched pairs).
DGCR8 was significantly upregulated in the STG and
DLPFC, whereas Drosha and Dicer were significantly
upregulated in the DLPFC only. Bars indicate mean fold
change (schizophrenia to control)þs.e.m. *P<0.05;
**P<0.01 unpaired Student’s t-test. (d) DGCR8 expression
was determined by Q-PCR in matched paired samples (SZ
vs CTR). DGCR8 was upregulated in 16 out of 21 matched
pairs of STG tissue and in 13 out of 15 matched pairs of
DLPFC tissue.
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genes in schizophrenia compared with those upregu-
lated.
5 This observation at the mRNA level has been
observed in other studies as well,
4,43,44 and may be
reflective of an elevation in global gene silencing
mediated by increased miRNA expression in these
tissues.
The question of why such an extensive and
consistent change in cortical miRNA expression was
seen in the schizophrenia group led to the considera-
tion of key components of the miRNA biogenesis
pathway. Significantly, we identified a corresponding
upregulation of the microprocessor component
DGCR8 mRNA in both the STG and DLPFC. This
alteration was consistent with an increase of both
mature miRNA and precursor forms of miR-181b and
miR-26b in the absence of a change in their level of
transcription. Although the mechanism behind this
Figure 4 Regulation of schizophrenia-associated reporter gene constructs by miRNA. (a) Sequence alignment showing miR-
107 and the miR-15 family seed region homology (gray highlight). Together, the two groups were predicted to have many
target genes in common (Venn diagram). (b) The pMIR-REPORT miRNA expression reporter system contains a firefly
luciferase gene under the control of the cytomegalovirus (CMV) promoter. Putative miRNA recognition elements for various
schizophrenia candidate genes were inserted into the multiple cloning site in the 30-UTR of the firefly luciferase gene
(HTR2A shown as an example). (c) A matrix chart showing the relative activity of reporter gene constructs (x-axis) in
response to co-transfected miRNA (dark bars) or their cognate anti-miR (light bars). Relative luciferase activity for each
reporter/miRNA/anti-miR combination was expressed as a percentage of the response to scrambled controls (þs.d.;
*P<0.05).
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level is currently unknown, the gene is situated
within a region of the genome that is prone to
spontaneous structural variation associated with
schizophrenia and other neurodevelopmental disor-
ders.
45–47 Microdeletion at this locus (22q11.2) is
responsible for the DiGeorge/Velocardiofacial syn-
drome, which is also strongly associated with schizo-
phrenia.
48 In a neurodevelopmental model, mice with
a specific deficiency in DGCR8 and miRNA biogen-
esis showed similar behavioral deficits to the larger
hemizygous deletion of a larger region of chromosome
16 syntenic to that of the 22q11 locus in humans.
49
Although the deletion model and human syndrome,
involving haploinsufficiency, does not accord with
the increased DGCR8 activity observed in this study,
the low copy repeats that give rise to deletion can also
induce microduplication. Interestingly, the syndrome
associated with duplication at this locus also appears
to be associated with behavioral abnormalities and
cognitive deficits akin to those seen in the deletion
syndrome, but, like schizophrenia, shows fewer
dysmorphic features.
50 As a consequence of this more
subtle phenotype, the frequency of this poorly
characterized syndrome may be underrepresented
through misdiagnosis.
50 Microduplications are also
more difficult to identify by classical cytogenetic
approaches than microdeletions, which may have
historically masked their relative abundance. In
theory, however, they are just as abundant as micro-
deletions, a view supported in a recent molecular
analysis of copy number variation, which found that
microduplications outnumbered microdeletions and
were more highly associated with schizophrenia.
47 In
view of these observations, it is possible that changes
in DGCR8 expression in some individuals could be
due to increased gene dosage through chromosomal
microduplication.
Alternatively, the increase in DGCR8 may be due to
transcriptional or post-transcriptional dysregulation.
A recent study has shown that DGCR8 is post-
transcriptionally autoregulated by its own micropro-
cessor complex.
51 Contrary to expectation, this is
probably not miRNA-mediated as the 30-UTR for
DGCR8 mRNA is almost devoid of predicted MREs,
an exception being an MRE for the microprocessor-
independent miRNA-intron or mirtron hsa-miR-
1227.
52 The mechanism is instead related to the
presence of primary miRNA-like hairpin structures
in the DGCR8 mRNA, which are themselves sub-
strates for cleavage by the microprocessor. Cleavage
results in destabilization of the mRNA and reduction
in DGCR8 expression.
51 Polymorphisms with a capa-
city to destabilize these secondary structures in the
Figure 5 Model for miRNA-associated dysregulation of synaptic structure and function in schizophrenia. The
microprocessor activity is elevated in cortical nuclei as a consequence of a schizophrenia-associated increase in DGCR8
expression. The increase in pri-miRNA processing results in an increase in pre-miRNAs, which are exported from the
nucleus and processed without delay by Exportin-5 (XPO5) and Dicer, respectively. Mature miRNAs are recruited into the
RNA-induced silencing complex (RISC) and associate with the 30-UTR of their target transcripts encoding synaptic
components (among other proteins), such as neurotropins/ligands (BDNF, Reelin), neurotransmitter receptors (GRM7,
GRIN3A, HTR2A, DRD1) and structural components of the post-synaptic density (DLG4). This association reduces the
stability of the transcript and reduces its ability to undergo translation. Inappropriate levels of mature miRNA and gene
silencing (red arrow) result in the reduction of synaptic proteins and consequently a loss of synaptic structure and function.
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DGCR8 elevation.
In conclusion, our data suggest that schizophrenia
is associated with a global increase in miRNA
biogenesis and expression in the cerebral cortex. This
could have profound neurodevelopmental and broad-
er neurological implications in the context of schizo-
phrenia by influencing genes involved in cortical
structure and neural plasticity. It also has significance
for our understanding of the mechanism underlying
patterns of cortical gene expression associated with
the disorder.
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